Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Izun Pharmaceuticals
AddedFeb 15, 2024
UpdatedJun 18, 2026
Izun Pharmaceuticals

Izun Pharmaceuticals

Pre-Seed

Izun Pharmaceuticals: Biopharmaceutical leader in non-steroidal oral anti-inflammatory periodontal therapies.

HQ
New York City, NY, US
Founded
2000
Overview
Compare
Fundraising
Employees
Website

Izun Pharmaceuticals, founded with a mission to revolutionize periodontal care, focuses on developing non-steroidal topical oral anti-inflammatory therapies. The company aims to provide superior efficacy and safety compared to current periodontal treatments. Their product portfolio is designed to address significant unmet needs in oral health, offering innovative solutions for patients suffering from periodontal diseases.

Notable figures affiliated with Izun Pharmaceuticals include leading experts in biopharmaceutical research and development. The company has attracted investment from prominent venture capital firms, underscoring its potential in the market. Izun Pharmaceuticals has achieved significant milestones in clinical trials, demonstrating the effectiveness of its therapies. Overall, the company is making a substantial impact on oral healthcare by providing safer and more effective treatment options.

Izun Pharmaceuticals - Similar Companies

Ziran Biopharmaceutical logo

Ziran Biopharmaceutical

Innocrin Pharmaceuticals logo

Innocrin Pharmaceuticals

innocrinpharma.com

Jazz Pharmaceuticals logo

Jazz Pharmaceuticals

jazzpharma.com

Concours Pharmaceuticals logo

Concours Pharmaceuticals

PIN Pharma logo

PIN Pharma

pinpharma.com

Forward Therapeutics logo

Forward Therapeutics

forward-tx.com

Sea Pharmaceuticals logo

Sea Pharmaceuticals

Zocere logo

Zocere

zocere.com

Attune Pharmaceuticals logo

Attune Pharmaceuticals

iQure Pharma logo

iQure Pharma

iqurepharma.com

Zai Lab logo

Zai Lab

zailaboratory.com

Zosano Pharma logo

Zosano Pharma

Navitor Pharmaceuticals logo

Navitor Pharmaceuticals

Oryza Pharmaceuticals logo

Oryza Pharmaceuticals

oryzapharma.com

Zurex Pharma logo

Zurex Pharma

zurexpharma.com

Izun Pharmaceuticals - Quick Facts

Who are Izun Pharmaceuticals' competitors?

Companies similar to Izun Pharmaceuticals include Ziran Biopharmaceutical, Innocrin Pharmaceuticals, Jazz Pharmaceuticals and Concours Pharmaceuticals.

When was Izun Pharmaceuticals founded?

Izun Pharmaceuticals was founded in 2000.

Where is Izun Pharmaceuticals' headquarters located?

Izun Pharmaceuticals' headquarters is located in New York City, NY, US.

When was Izun Pharmaceuticals' last funding round?

Izun Pharmaceuticals' most recent funding round was for $1.1M (USD) in November 2014.

How much has Izun Pharmaceuticals raised to-date?

As of Nov 13, 2014, Izun Pharmaceuticals has raised a total of $5.2M (USD).

How many employees does Izun Pharmaceuticals have?

Izun Pharmaceuticals has 33 employees as of Feb 5, 2024.

Izun Pharmaceuticals - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2835In Vitro And In Vivo Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified